Synthetic Biology & Tools

CRISPR. Polymerases. Enzyme Systems. Tools for the Future of Life.

At Mika Biologics, we believe synthetic biology isn’t just an industry—it’s a revolution. Synbio companies are rewriting the code of life, engineering microbes, designing genetic circuits, building biomaterials, and reshaping the future of therapeutics, diagnostics, food, and beyond.

At the heart of this revolution lie tools: enzymes, CRISPR proteins, polymerases, ligases, restriction enzymes, recombinases. These are the workhorses of synthetic biology—without them, nothing moves forward.

Yet producing these tools at scale, with GMP readiness and clinical reliability, is a challenge most CDMOs aren’t built to handle. That’s where Mika comes in. We are a specialist microbial-first CDMO, built to manufacture the tools of synthetic biology with unmatched expertise, speed, and precision.

We are not just participants in synbio—we are its enablers. We position ourselves as the best synbio tools CDMO in the U.S., the world, and the galaxy.

What Synthetic Biology Companies Value

Synbio innovators move fast, operate lean, and depend on partners who understand their unique needs. What they value most:

1. Reliable, High-Quality Tool Proteins

CRISPR nucleases, polymerases, ligases, and engineered enzymes must perform with fidelity, reproducibility, and scalability. Off-the-shelf isn’t enough. Synbio companies need custom-grade, validated proteins.

2. Speed of Iteration

Synbio thrives on iteration. Every cycle of design–build–test–learn must be shortened. Mika’s microbial-first and cell-free platforms enable rapid prototyping, cutting weeks to months off cycles.

3. GMP Readiness

Many synbio tools begin as research reagents but must progress to diagnostic-grade or clinical-grade biologics. Mika provides seamless scale-up with GMP compliance.

4. Flexibility in Scale

From milligram discovery batches to kilogram GMP lots, synbio companies need partners who scale flexibly without compromising quality.

5. Advanced Engineering Support

Enzyme engineering, directed evolution, glycoengineering—synbio companies need partners who solve complexity, not just follow recipes.

Current Technical Needs in Synthetic Biology & Tools

The synthetic biology sector is dynamic, but a few needs stand out:

1. CRISPR Proteins

Cas9, Cas12, Cas13, and engineered nucleases are central to genome editing and diagnostics. Synbio companies need custom, high-purity CRISPR proteins validated in activity assays.

2. Polymerases & Ligases

High-fidelity polymerases and thermostable ligases power NGS, PCR, isothermal amplification, and DNA assembly. Companies need fast, accurate, GMP-ready enzyme supply.

3. Custom Enzymes

Novel restriction enzymes, recombinases, de novo designed catalysts—synbio demands enzymes nature never built.

4. Enzyme Engineering & Evolution

Companies push for faster, more stable, more precise enzymes. Directed evolution pipelines and rational design are essential.

5. Cell-Free Systems

Cell-free transcription–translation extracts are essential for rapid prototyping and parallel enzyme libraries.

6. Diagnostics-Grade Reagents

CRISPR nucleases, polymerases, ligases validated for point-of-care diagnostics. Ultra-low endotoxin, consistent activity.

7. GMP Transition

Synbio startups need partners who bridge R&D reagents to clinical-grade supply.

Innovation in the Synbio Sector Today

Mika aligns directly with where synbio is headed:

• Next-Gen CRISPR Systems – CasΦ, compact nucleases, RNA editors.
• AI-Designed Enzymes – predictive models generating synthetic enzymes.
• DNA Synthesis & Assembly – polymerases & ligases designed for synthetic genome construction.
• Diagnostics Revolution – CRISPR-based diagnostics moving from lab to clinic.
• Engineered Microbes – microbial consortia producing biomaterials, fuels, and proteins.
• Nanobiotechnology – biologic nanoparticles as scaffolds, carriers, and devices.
• Cell-Free Factories – portable, distributed biomanufacturing powered by microbial extracts.

How Mika Delivers Value to Synthetic Biology Companies

1. Reliable Supply of Tool Proteins

We manufacture CRISPR nucleases, polymerases, ligases, and custom enzymes with high activity, purity, and reproducibility.

2. Faster Innovation Cycles

Our cell-free extracts enable rapid enzyme prototyping and screening.

3. GMP Pathways

We scale tools from research reagent → diagnostic grade → GMP clinical grade.

4. Regulatory Advantage

We support IND/CTA filings for synbio tools used in diagnostics or therapies.

5. Strategic Partnership

We act as co-builders, helping synbio startups solve problems and scale.

Technical Capabilities That Matter to Synbio

• Fermentation: E. coli, yeast, fungi, engineered hosts (1–2000 L, 20,000 L with partners).
• Downstream: chromatography, refolding, lyophilization.
• Analytics: activity assays, fidelity testing, structural validation.
• Engineering: directed evolution, rational design, glycoengineering.
• Quality Systems: GMP-ready, FDA/EMA-compliant, IND/diagnostic support.

Case Examples

• CRISPR Startup – partnered with Mika to produce GMP Cas12 enzymes for diagnostic kits.
• NGS Innovator – high-fidelity polymerase scaled from 1 L bench to 500 L fermentation.
• Synbio Pioneer – custom ligase engineered for synthetic genome assembly.
• Diagnostics Provider – enzymes validated for point-of-care CRISPR test kits.

Top 10 Technical FAQs for Synthetic Biology & Tools

1. What tool proteins does Mika specialize in?
CRISPR nucleases, polymerases, ligases, recombinases, restriction enzymes, custom enzymes.

2. Can Mika engineer new enzymes?
Yes—directed evolution + rational design pipelines.

3. Do you provide cell-free systems for synbio prototyping?
Yes—custom microbial TX–TL extracts tailored for enzyme libraries.

4. How does Mika validate enzyme activity?
Fidelity, cleavage, amplification, and ligation assays; structural validation.

5. What scale can Mika support?
From mg discovery batches → multi-kg GMP supply.

6. Does Mika support diagnostics-grade production?
Yes—low endotoxin, reproducible enzymes validated for clinical diagnostics.

7. How fast can Mika deliver CRISPR proteins?
Weeks from sequence to purified nuclease; GMP transition within months.

8. Can Mika handle unusual or novel enzymes?
Yes—custom restriction enzymes, recombinases, or synthetic designs.

9. Does Mika provide GMP for synbio tools?
Yes—IND/CTA-ready, FDA/EMA-compliant.

10. Why Mika vs. other CDMOs?
We are the only microbial-first CDMO specializing in synbio tools.

The Future of Synthetic Biology with Mika

We see synthetic biology as the operating system of biology. Tools are the APIs—enzymes, nucleases, polymerases—through which life is rewritten. Mika is building the platform CDMO for synthetic biology, with:

• AI-Powered Enzyme Design – predictive fidelity & stability modeling.
• Plug-and-Play Enzyme Libraries – pre-engineered tools ready for rapid deployment.
• Cross-Platform Synergy – CRISPR tools supporting probiotics, nanoparticles, immune biologics.
• Distributed Manufacturing – portable tool protein production systems for global labs.
• Galaxy-Class Leadership – setting the global standard for synbio CDMO excellence.

Closing Statement

Synthetic biology is rewriting life. But it can only move as fast as its tools allow. CRISPR proteins, polymerases, ligases, and custom enzymes are the infrastructure of innovation.

At Mika Biologics, we are the only CDMO to make synthetic biology tools a dedicated flagship platform. With microbial-first mastery, GMP readiness, and technical innovation, we deliver the enzymes that power the future.

We don’t just supply tools—we build the engine of synthetic biology.

Mika Biologics. Microbial Systems. Immune Innovation. Beyond the Cell.

Need help? Contact our team at info@mikabiologics.com